June 12, 2015

Hematopoietic progenitor cells (HPCs) are found in cord blood, bone marrow, and peripheral blood and can be collected through umbilical cord blood banking. HPCs are blood-forming stem cells that can be used in the treatment of different types of cancers, blood disorders, immune disorders, and anemia treatment.

The HPCs found in cord blood are considered by medical professionals to be “immature” cells and are not required to be an exact match to be considered compatible, a prerequisite for HPCs found in bone marrow or other blood sources. This is why HPC cells collected through umbilical cord blood banking after a mother’s pregnancy stages are more flexible and can be used more broadly than HPC bone marrow cells. Additionally, cord blood researchers have found that patients will not experience as many adverse reactions from cord blood HPCs, compared to HPCs taken from other blood sources. This is because the body is less likely to view the cells as a threat and attack them, and another reason for expecting mothers to consider umbilical cord blood banking during their stages of pregnancy.

Because umbilical cord blood is rich in HPCs, it is a vital resource in treating cancer, blood disorders, immune disorders, and can be utilized for anemia treatment. This is why it is important for expecting mothers to become aware of the many benefits of cord blood during their early pregnancy stages, so they can make an informed decision to potentially bank their child’s cord blood before their stages of pregnancy end. Once a baby has been born, the opportunity to save their cord blood has passed.

FaceBook  Twitter